Trial intelligence / Profile preview

Paclitaxel in Advanced Refractory AIDS-KS

NCT00002189Phase 2Completed

Sponsor
Baker Norton Pharmaceutical
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of paclitaxel in Kaposi sarcoma (KS), sponsored by Baker Norton Pharmaceutical. Status: completed.

02

Drugs

paclitaxel
03

Conditions

Kaposi sarcoma (KS)

Beyond the preview

Go deeper on NCT00002189.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00002189.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call